Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 13.069bis | Other Identifier | CCTIRS |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agence Régionale de Santé Rhône-Alpes | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cognitive and behavioral units (CBUs) have been created between 2008 and 2012 French National Alzheimer plan for the management of behavior problems of patients suffering from Alzheimer's disease or other related disorders and necessitating hospitalisation. This Alzheimer plan is promoting the evaluation of these units through the observation of the behavioral and psychological symptoms of dementia (BPSD) evolution. As these units are new, it appears important to assess their long-term impact on patients care.
EXPECTED RESULTS The present study should allow to better understand the long-term impact of CBU on care of patients with Alzheimer disease and BPSD. Moreover, it should allow to identify patients improved by CBU.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patient with alzheimer's disease | Cohort of patients with psychological symptoms of dementia hospitalised in Cognitive and Behaviorial Units (CBUs) Evaluation of these units through the observation of the behavioral and psychological symptoms of dementia evolution : NPI score, caregivers quality of life, caregivers burden, collection of psychotropic drugs, the rehospitalisation rate |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| patients with alzheimer's disease | Behavioral | the Neuropsychiatric Inventory (NPI), is uded to assess 10 behavioral disturbances occurring in dementia patients: delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity. The NPI uses a screening strategy to minimize administration time, examining and scoring only those behavioral domains with positive responses to screening questions. |
| Measure | Description | Time Frame |
|---|---|---|
| Neuropsychiatric Inventory (NPI) score | impact of CBU effectiveness in reducing BPSD | one year |
| Measure | Description | Time Frame |
|---|---|---|
| CBU effectiveness in reducing BPSD | 6 months | |
| CBU effectiveness on quality of life of patients and caregivers, and on caregivers' burden | one year | |
| Psychotropic drugs (in particular neuroleptic drugs) consumption |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with Alzheimer's disease or associated disorders and BDSP and hospitalized in a CBU
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Isabelle ROUCH, PhD | CHU de Saint-Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CH Saint Jean de Dieu | Lyon | 69373 | France | |||
| CHU de Saint Etienne |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25398578 | Derived | Pongan E, Freulon M, Delphin-Combe F, Dibie-Racoupeau F, Martin-Gaujard G, Federico D, Waissi A, Richard G, Jacqueline S, Fabre F, Trombert-Paviot B, Krolak-Salmon P, Laurent B, Rouch I. Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study design. BMC Psychiatry. 2014 Nov 15;14:308. doi: 10.1186/s12888-014-0308-6. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D003704 | Dementia |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
Not provided
Not provided
| ID | Term |
|---|---|
| D016564 | Amyloid beta-Protein Precursor |
| ID | Term |
|---|---|
| D058227 | Amyloidogenic Proteins |
| D000682 | Amyloid |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| one year |
| rehospitalisation rate for BPSD of the patients in the year following their hospitalisation in CBU | one year |
| Saint-Etienne |
| 42000 |
| France |
| Hospices Civils de Lyon | Villeurbanne | 69100 | France |
| D019636 |
| Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D008565 |
| Membrane Proteins |
| D011498 | Protein Precursors |
| D058255 | Protease Nexins |
| D053491 | Proteinase Inhibitory Proteins, Secretory |